FibroBiologics, Inc. (FBLG)

Latest Insider Confidence Score

2026Q1

62.7
Bullish

Company insider confidence (by quarter)

2024Q1 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
O'Heeron Pete CEO 5,906,647 Dec 9, 2024
Andersen Mark C. 463,250 Aug 13, 2024
Garcia Ruben A General Counsel 180,000 Mar 8, 2024
Khoja Hamid Chief Scientific Officer 31,250 May 27, 2025
Niklas Victoria Ninon Olivia 5,000 Aug 27, 2024

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 4, 2026 Mar 5, 2026 Khoja Hamid Chief Scientific Officer Buy 91.3 +30,000 96.00% $11.4K
Mar 2, 2026 Mar 4, 2026 O'HEERON PETE CEO Buy 68.8 +51,500 0.87% $19.5K
Mar 2, 2026 Mar 3, 2026 Davis Jason CFO Buy 91.3 +70,000 100.00% $29K
Feb 27, 2026 Mar 2, 2026 GARCIA RUBEN A General Counsel Buy 91.3 +40,000 28.57% $13.1K
Dec 11, 2025 Dec 12, 2025 GARCIA RUBEN A General Counsel Buy 91.3 +140,000 100.00% $47.6K
Jun 12, 2025 Jun 12, 2025 Niklas Victoria Ninon Olivia Director Neutral 52.5 - 0.00% -
Jun 12, 2025 Jun 12, 2025 Link Matthew Director Neutral 52.5 - 0.00% -
Jun 12, 2025 Jun 12, 2025 Hoffman Robert E. Director Neutral 52.5 - 0.00% -
Jun 12, 2025 Jun 12, 2025 Coen Stacy Ann Director Neutral 52.5 - 0.00% -
Jun 12, 2025 Jun 12, 2025 Cilento Richard C. Jr. Director Neutral 52.5 - 0.00% -
Jun 9, 2025 Jun 10, 2025 Davis Jason CFO Neutral 52.5 - 0.00% -
Jun 10, 2025 Davis Jason CFO Neutral 52.5 - 0.00% -
May 27, 2025 May 27, 2025 Khoja Hamid Chief Scientific Officer Buy 91.3 +20,000 177.78% $16.8K
Mar 26, 2025 Mar 28, 2025 O'HEERON PETE CEO Neutral 52.5 - 0.00% -
Mar 26, 2025 Mar 28, 2025 GARCIA RUBEN A General Counsel Neutral 52.5 - 0.00% -
Mar 26, 2025 Mar 28, 2025 Khoja Hamid CHIEF SCIENTIFIC OFFICER Neutral 52.5 - 0.00% -
Dec 27, 2024 Dec 30, 2024 O'HEERON PETE CEO Neutral 52.5 - 0.00% -
Dec 27, 2024 Dec 30, 2024 Khoja Hamid CHIEF SCIENTIFIC OFFICER Neutral 52.5 - 0.00% -
Dec 27, 2024 Dec 30, 2024 GARCIA RUBEN A General Counsel Neutral 52.5 - 0.00% -
Dec 9, 2024 Dec 9, 2024 O'HEERON PETE CEO Neutral 27.5 -100,000 -1.66% -
Dec 3, 2024 Dec 5, 2024 O'HEERON PETE CEO Neutral 37.5 -50,000 -0.83% -
Aug 27, 2024 Aug 27, 2024 Niklas Victoria Ninon Olivia Director Neutral 52.5 - 0.00% -
Aug 27, 2024 Aug 27, 2024 Link Matthew Director Neutral 52.5 - 0.00% -
Aug 27, 2024 Aug 27, 2024 Hoffman Robert E. Director Neutral 52.5 - 0.00% -
Aug 27, 2024 Aug 27, 2024 Coen Stacy Ann Director Neutral 52.5 - 0.00% -
Aug 27, 2024 Aug 27, 2024 Cilento Richard C. Jr. Director Neutral 52.5 - 0.00% -
Aug 13, 2024 Cilento Richard C. Jr. Director Neutral 52.5 - 0.00% -
Aug 13, 2024 Andersen Mark C. CFO Neutral 52.5 - 0.00% -
Aug 13, 2024 Link Matthew Director Neutral 52.5 - 0.00% -
Aug 13, 2024 Hoffman Robert E. Director Neutral 52.5 - 0.00% -
Aug 13, 2024 Niklas Victoria Ninon Olivia Director Neutral 52.5 - 0.00% -
Aug 13, 2024 Coen Stacy Ann Director Neutral 52.5 - 0.00% -
Aug 12, 2024 Aug 12, 2024 O'HEERON PETE CEO Buy 56.3 +8,500 0.14% $16.3K
Aug 12, 2024 Aug 12, 2024 Khoja Hamid Chief Scientific Officer Buy 91.3 +10,000 800.00% $19K
Aug 12, 2024 O'HEERON PETE CEO Neutral 52.5 - 0.00% -
Aug 12, 2024 Khoja Hamid Chief Scientific Officer Neutral 52.5 - 0.00% -
Mar 1, 2024 Mar 8, 2024 GARCIA RUBEN A General Counsel Neutral 52.5 - 0.00% -
Mar 6, 2024 GARCIA RUBEN A General Counsel Neutral 52.5 - 0.00% -
Feb 15, 2024 Niklas Victoria Ninon Olivia Director Neutral 52.5 - 0.00% -
Feb 13, 2024 Coen Stacy Ann Director Neutral 52.5 - 0.00% -
Feb 13, 2024 Link Matthew Director Neutral 52.5 - 0.00% -
Feb 8, 2024 Khoja Hamid Chief Scientific Officer Neutral 52.5 - 0.00% -
Feb 8, 2024 O'HEERON PETE CEO Neutral 52.5 - 0.00% -
Feb 7, 2024 Hoffman Robert E. Director Neutral 52.5 - 0.00% -
Feb 7, 2024 Cilento Richard C. Jr. Director Neutral 52.5 - 0.00% -
Feb 7, 2024 Andersen Mark C. CFO Neutral 52.5 - 0.00% -